Recent News for SABS - SAB Biotherapeutics, Inc.

Date	Title
May 21	FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
May 20	SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates